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Most processes in the cell must be strictly controlled to ensure that they occur only when and where they should. The pro-
teins that carry out these processes are often 
regulated by modifying them so as to turn them 
on or off, or to influence their interactions with 
other proteins. One such modification is ubiquitin, 
a small protein that can be linked to target pro-
teins to regulate their behaviour. A trio of enzymes, 
called E1, E2 and E3, are responsible for activat-
ing a ubiquitin molecule and then attaching it to 
a target protein in a process known as ubiquityla-
tion (Figure 1).
By bringing together a target protein with 
activated ubiquitin, the E3 enzyme catalyses the 
transfer of this ubiquitin to a specific amino acid 
residue within the target (a lysine) (Komander and 
Rape, 2012). However, the details of this process 
are not well understood. Now, in eLife, a group 
led by Brenda Schulman, of the St Jude Children’s 
Research Hospital in Memphis, and Brian Kuhlman, 
of the University of North Carolina at Chapel 
Hill, report that they have used structural and 
biochemical assays to explore how an essential 
E3 enzyme modifies specific residues in target 
proteins (Kamadurai et al., 2013).
Schulman, Kuhlman and co-workers—including 
Hari Kamadurai as first author—have captured 
the moment when Rsp5, an E3 enzyme that is 
essential in yeast, transfers a ubiquitin molecule 
to a lysine residue within a target protein called 
Sna3. E3s comprise a large class of enzymes, with 
more than 600 members in human cells; Rsp5 
belongs to the HECT family of E3 enzymes, which 
can regulate essential transcription factors, intra-
cellular trafficking, or the cellular response to stress 
(Rotin and Kumar, 2009). Accordingly, mutations 
in genes encoding HECT E3s can lead to several 
diseases, among them inflammatory syndromes 
or hypertension.
The catalytic portion of the HECT E3 enzyme, 
which adds ubiquitin to the target protein, is called 
the HECT domain; this region is composed of two 
lobes—the N-lobe and the C-lobe—that are con-
nected by a flexible linker. Intriguingly, previous 
research suggested that these lobes might adopt 
a variety of positions with respect to each other 
during the attachment of ubiquitin to the target 
protein. Moreover, it appeared that there might 
be a considerable distance between the relevant 
lysine in the target protein and the active (catalytic) 
site of the HECT domain (Verdecia et al., 2003; 
Kamadurai et al., 2009). These details have 
frustrated attempts to model how HECT E3s might 
transfer ubiquitin to a target protein and, in partic-
ular, to a specific residue in that target.
The C-lobe of the HECT domain contains a 
cysteine residue, which is charged with ubiquitin 
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through a thioester bond to create an essential 
catalytic intermediate also found in a few other 
classes of E3 enzymes (Wenzel et al., 2011). The 
C-lobe also provides a site for non-covalent in-
teraction with ubiquitin: this stabilizes the cova-
lent bond between ubiquitin and the E3 enzyme, 
and it also helps to transfer ubiquitin to the target 
protein (Kamadurai et al., 2009; Maspero et al., 
2013). The N-lobe possesses a key binding site 
for E2 enzymes, which load ubiquitin onto the 
active site of the HECT E3 (Figure 1) (Kamadurai 
et al., 2009). Using a bivalent crosslinker attached 
to a specific site in a target peptide, Kamadurai 
et al. revealed that the transfer of ubiquitin from 
the E3 enzyme to the target protein coincides 
with a dramatic re-organization of the HECT 
domain, with the C-lobe swinging through an 
angle of ∼130° to place the catalytic centre next 
to the target lysine.
In addition to closing the gap between the 
active site and the modified lysine, this rear-
rangement produces a large region of interaction 
between the two lobes of the HECT domain that 
serves important functions. First, it clamps down 
on the flexible C-terminal tail of ubiquitin, thereby 
orienting the thioester bond for nucleophilic 
attack by the lysine on the target protein. It also 
leads to formation of a composite active site that 
contains both the catalytic cysteine in the C-lobe 
and an acidic residue of the N-lobe that might 
orient or deprotonate the substrate lysine. Lastly, 
the arrangement of the catalytically engaged 
HECT domain restricts the flexibility of the active 
site relative to the portion of the E3 that associ-
ates with the target protein, a feature that ena-
bles the enzyme to prioritize the lysine that is 
modified in vivo. Other E3 enzymes have recently 
been seen to tether the activated ubiquitin during 
catalysis (Saha et al., 2011; Wickliffe et al., 
2011; Dou et al., 2012; Plechanovová et al., 
2012; Pruneda et al., 2012), and the orientation 
of the catalytic site relative to motifs that can 
interact with target proteins might also help to 
determine how E3s with different catalytic domains 
select lysines to modify on target proteins (Wu 
et al., 2003; Williamson et al., 2011). The pre-
sent findings therefore raise the exciting hypo-
thesis that very different classes of E3 enzymes 
evolved similar mechanisms to modify target pro-
teins rapidly and specifically.
In addition to adding a single ubiquitin to a 
lysine within a target protein, HECT E3s can also 
assemble polymeric ubiquitin chains that are 
connected through one of a few dedicated lysines 
of ubiquitin (lysines 29, 48 or 63) (Rotin and Kumar, 
2009). Previous studies have found that the C-lobe 
Figure 1. Three enzymes are needed to activate 
ubiquitin and attach it to a target protein. (A) Ubiquitin 
(green) is activated by an E1 enzyme and becomes 
covalently linked to a cysteine residue in the active site 
of the enzyme (all active sites are marked in yellow). 
The ubiquitin is then transferred to a cysteine residue in 
the active site of an E2 enzyme, which delivers it to a 
cysteine residue in the active site of the E3 enzyme’s 
HECT domain. In each case ubiquitin is attached to the 
enzyme by a thioester bond. The E3 then catalyses the 
transfer of the ubiquitin to a target protein (blue; labelled 
‘tar’). (B) Kamadurai et al. have studied the last stage of 
this process in detail for an E3 enzyme called Rsp5. 
The HECT domain of the E3 enzyme is composed of an 
N-lobe (which binds the E2 enzyme) and a C-lobe, which 
contains the active site (yellow) and also a non-covalent 
binding site that stabilizes the ubiquitin. The target 
protein is detected by Rsp5 through an additional 
domain called the WW3 domain (top panel). The C-lobe 
then undergoes a major rearrangement that leads to 
Figure 1. Continued on next page
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of the HECT domain can determine which one 
of these lysines is used in chain formation (Kim 
and Huibregtse, 2009), while Kamadurai et al. 
point to a requirement for N-lobe residues in 
coordinating this process. It will be interesting 
to see if HECT E3s can also be ‘caught in the 
act’ of assembling a chain, as this could reveal 
how multiple interactions contributed by several 
domains of the enzyme establish catalytic efficiency 
and specificity.
Collectively, these new insights underscore 
the importance of structural rearrangements for 
catalysis, a phenomenon that might be referred 
to as macromolecular juggling (Lorenz et al., 
2013). Pessimists might view these idiosyncrasies 
of ubiquitylation reactions as posing challenges 
to the identification of small molecules that can 
target disease-relevant E3s. Optimists, however, 
might see the architectural changes that occur 
during ubiquitylation as providing opportunities 
for drug discovery. Hopefully, innovative approaches 
such as those documented in this study will help 
to harness the potential of ubiquitylation enzymes 
for therapeutic purposes.
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the formation of a composite active site comprising 
residues of both N- and C-lobes. This rearrangement 
also places the active site in proximity to the target 
protein (second panel), which helps the enzyme to 
select specific lysine residues in the target protein for 
modification (third panel). The ubiquitylated target 
protein is then released (bottom panel).
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